NeuroMetrix Resultados de beneficios anteriores
Pasado controles de criterios 0/6
NeuroMetrix's earnings have been declining at an average annual rate of -16.3%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 11.3% per year.
Información clave
-16.3%
Tasa de crecimiento de los beneficios
51.8%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 4.3% |
| Tasa de crecimiento de los ingresos | -11.3% |
| Rentabilidad financiera | -45.8% |
| Margen neto | -181.0% |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero NeuroMetrix. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 4 | -8 | 9 | 2 |
| 31 Mar 24 | 5 | -8 | 9 | 3 |
| 31 Dec 23 | 6 | -7 | 9 | 3 |
| 30 Sep 23 | 6 | -6 | 8 | 2 |
| 30 Jun 23 | 7 | -5 | 8 | 3 |
| 31 Mar 23 | 8 | -5 | 8 | 3 |
| 31 Dec 22 | 8 | -4 | 7 | 3 |
| 30 Sep 22 | 8 | -5 | 7 | 3 |
| 30 Jun 22 | 8 | -4 | 7 | 3 |
| 31 Mar 22 | 8 | -3 | 6 | 3 |
| 31 Dec 21 | 8 | -2 | 6 | 2 |
| 30 Sep 21 | 8 | -2 | 6 | 1 |
| 30 Jun 21 | 8 | -1 | 6 | 1 |
| 31 Mar 21 | 7 | -1 | 5 | 1 |
| 31 Dec 20 | 7 | -2 | 6 | 2 |
| 30 Sep 20 | 7 | -3 | 6 | 2 |
| 30 Jun 20 | 7 | -4 | 7 | 1 |
| 31 Mar 20 | 8 | -6 | 9 | 2 |
| 31 Dec 19 | 9 | -4 | 11 | 2 |
| 30 Sep 19 | 11 | -6 | 13 | 3 |
| 30 Jun 19 | 13 | -3 | 14 | 4 |
| 31 Mar 19 | 14 | 1 | 15 | 4 |
| 31 Dec 18 | 16 | 0 | 15 | 5 |
| 30 Sep 18 | 17 | 0 | 16 | 4 |
| 30 Jun 18 | 17 | -7 | 17 | 4 |
| 31 Mar 18 | 18 | -11 | 17 | 3 |
| 31 Dec 17 | 17 | -20 | 17 | 3 |
| 30 Sep 17 | 16 | -20 | 17 | 3 |
| 30 Jun 17 | 16 | -17 | 17 | 3 |
| 31 Mar 17 | 14 | -38 | 16 | 4 |
| 31 Dec 16 | 12 | -35 | 16 | 4 |
| 30 Sep 16 | 11 | -43 | 16 | 4 |
| 30 Jun 16 | 10 | -42 | 15 | 4 |
| 31 Mar 16 | 8 | -23 | 14 | 3 |
| 31 Dec 15 | 7 | -21 | 13 | 3 |
| 30 Sep 15 | 6 | -13 | 12 | 3 |
| 30 Jun 15 | 5 | -11 | 11 | 3 |
| 31 Mar 15 | 5 | -12 | 10 | 3 |
| 31 Dec 14 | 6 | -11 | 8 | 3 |
| 30 Sep 14 | 6 | -12 | 7 | 3 |
| 30 Jun 14 | 5 | -11 | 7 | 3 |
| 31 Mar 14 | 5 | -8 | 7 | 2 |
| 31 Dec 13 | 5 | -9 | 8 | 3 |
Ingresos de calidad: NLZ0 is currently unprofitable.
Margen de beneficios creciente: NLZ0 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: NLZ0 is unprofitable, and losses have increased over the past 5 years at a rate of 16.3% per year.
Acelerando crecimiento: Unable to compare NLZ0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: NLZ0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Rentabilidad financiera
Alta ROE: NLZ0 has a negative Return on Equity (-45.84%), as it is currently unprofitable.